Status:
COMPLETED
Changes in Plasma Amino Acid Appearance After Adding Bacillus Coagulans GBI-30, 6086 to Milk Protein Concentrate
Lead Sponsor:
Lindenwood University
Collaborating Sponsors:
Increnovo, LLC
Conditions:
Protein Malabsorption
Eligibility:
FEMALE
50-70 years
Phase:
NA
Brief Summary
The purpose of this study is to examine the pattern of plasma amino acid appearance after a two-week daily regimen of milk protein concentrate supplementation with and without the addition of Bacillus...
Detailed Description
Once determined eligible and providing consent, participants will be assigned in a randomized, double-blind, crossover fashion to ingest a single daily 25-gram dose of a milk protein concentrate or a ...
Eligibility Criteria
Inclusion
- All participants will be between the ages of 50-70 years
- Completing at least 30 minutes of physical activity at minimum three days per week
Exclusion
- As indicated on a medical history form they complete, any individual who is currently being treated for or diagnosed with a cardiac, respiratory, circulatory, musculoskeletal, metabolic, obesity (defined as body mass index \> 30 kg/m2), immune, autoimmune, psychiatric, hematological, neurological or endocrinological disorder or disease
- Any woman who is taking a medication known to impact digestive function or hormonal functions that may impact how our body digests, absorbs, or metabolizes nutrients
- Any woman currently taking a probiotic or a dietary supplement that may impact digestive function or hormonal functions that may impact how our body digests, absorbs, or metabolizes nutrients
- Participants who are determined to not be weight stable defined as measured body mass deviating by 2% or more.
- Participants who do not or are not willing to abstain from alcohol, nicotine, and caffeine for overnight (8-10 hours)
- Participants who do not or are not willing to abstain from exercise for 24 hours prior to each visit
- Women who are pregnant
- Women who are lactose intolerant
Key Trial Info
Start Date :
November 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05313178
Start Date
November 20 2020
End Date
February 1 2022
Last Update
October 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lindenwood University
Saint Charles, Missouri, United States, 63301